AFWERX Contract Awarded to IC2 for Calibrated MHz-Bandwidth Pressure Sensors
UF startup Interdisciplinary Consulting Corporation (IC2), a technology-development company commercializing miniaturized instrumentation that monitors the health of aerospace propulsion systems and enables reduced aircraft noise and improved fuel efficiency, was awarded an AFWERX Phase 1 contract for Calibrated, MHz-Bandwidth, Dynamic Pressure Sensors for Quantitative Measurements in Hypersonic Flows through the SBIR program. AFWERX is a […]
Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has submitted for ethics approval in Australia for its planned Phase 2 study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough. Ethics submission is the next step in the company’s clinical development program […]
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), and Inovio Pharmaceuticals Inc., a company developing DNA medicines for infectious diseases and cancer, announced that the Department of Defense (DOD) has awarded Ology Bioservices with a contract valued at $11.9 million to work with Inovio on […]
COVID-19 Expert Nursing Panel Q & A
UF startup Shadow Health, an educational technology company, facilitated a panel discussion and Q & A with the Global Nursing Education Virtual Simulation Consortium on the topic of Clinical Hour Replacement in the Face of the COVID-19 Pandemic. Learn more about COVID-19 Expert Nursing Panel Q & A.
Sun BioPharma Provides Business Update and Reports Operating Results for FY2019
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic cancer, provided a business update and reports financial results for the year ended December 31, 2019. Sun BioPharma is developing SBP-101, a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance […]
Algernon Appoints Novotech As CRO for Phase 2 Coronavirus Ifenprodil Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, announced that it has chosen to appoint award winning Novotech as the contract research organization (CRO) for a planned physician initiated study of NP-120 (Ifenprodil) for COVID-19 infected patients in South Korea. Novotech is an internationally recognized full service CRO known for its experience across […]
Digital Mental Health Solution Offers Group Teletherapy to Universities
UF startup and UF Innovate | The Hub graduate company TAO Connect, a digital platform designed to make behavioral health therapy more accessible and effective, announced the addition of its Group Room feature, while also offering its video conferencing services to all 180 of its university partners. With this update, TAO Connect is giving more […]
Clinical Trial of Radiation Therapy Offers Complete Treatment in Fewer Visits
Diagnosed with invasive ductal carcinoma, one of the most common types and earliest stages of breast cancer, Michele, a grandmother and full-time caregiver to her husband, is today cancer-free thanks to the radiation therapy she received at the Siteman Cancer Center. The clinical trial was based on the use of the breakthrough ViewRay MRIdian technology, […]
Molekule Research: The Research and Innovation Behind The Filter Technology
UF startup Molekule Director of R&D Jaspreet Dhau and Co-Founder and Co-CEO Dilip Goswami explains how research, science, and innovation play a role in furthering the PECO (Photo Electrochemical Oxidation) technology, and how that extends to improving the lives of their customers.
AGTC Announces Completion of Enrollment in All Adult Dose Groups of Its Ongoing Phase 1/2 Clinical Trials in Patients With Achromatopsia
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including […]